Taha Al-Adhami is a Research Assistant in Medicinal Chemistry and a PhD candidate at the School of Cancer and Pharmaceutical Sciences, King’s College London. After obtaining an MSc in Pharmaceutical Sciences from the University of Greenwich, he worked for a year in the pharmaceutical industry as a Quality Control Analyst at Bristol Laboratories Ltd. This industry experience paved the way for his current role in Dr. Rahman's research group at King’s College London. Taha's primary research interest focused on the application of synthetic medicinal chemistry and chemical biology techniques, including the design, synthesis, and evaluation of novel drug-like chemical scaffolds, primarily aimed at serving as antibacterial and anticancer agents.
He has been actively engaged in several projects aimed at developing next-generation antibiotics, including work with oxazolidinone antibiotics, fluoroquinolones, and pyrrolobenzodiazepine monomers, to treat both Gram-positive and Gram-negative MDR infections. Furthermore, Taha is contributing to the development of Heme Oxygenase inhibitors as novel chemotherapeutic agents, a work that has been filed for a patent.